Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 2
2000 2
2001 1
2002 3
2003 2
2004 1
2005 6
2006 4
2007 6
2008 4
2009 4
2010 4
2011 4
2012 3
2013 4
2014 3
2015 2
2016 2
2017 4
2021 2
2023 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
Hokusai-VTE Investigators; Büller HR, Décousus H, Grosso MA, Mercuri M, Middeldorp S, Prins MH, Raskob GE, Schellong SM, Schwocho L, Segers A, Shi M, Verhamme P, Wells P. Hokusai-VTE Investigators, et al. N Engl J Med. 2013 Oct 10;369(15):1406-15. doi: 10.1056/NEJMoa1306638. Epub 2013 Aug 31. N Engl J Med. 2013. PMID: 23991658 Free article. Clinical Trial.
[Hyperbaric oxygen therapy in outpatient care].
Szolnoki N, Gasztonyi B, Paizs T, Földi I, Németh L, Sződy R. Szolnoki N, et al. Among authors: gasztonyi b. Orv Hetil. 2023 Jun 25;164(25):993-997. doi: 10.1556/650.2023.32802. Print 2023 Jun 25. Orv Hetil. 2023. PMID: 37356018 Hungarian.
[Statins and gastrointestinal cancers].
Sági V, Herszényi L, Tulassay Z, Gasztonyi B. Sági V, et al. Among authors: gasztonyi b. Orv Hetil. 2014 May 4;155(18):687-93. doi: 10.1556/OH.2014.29901. Orv Hetil. 2014. PMID: 24776382 Review. Hungarian.
Aspirin resistance: focus on clinical endpoints.
Pusch G, Feher G, Kotai K, Tibold A, Gasztonyi B, Feher A, Papp E, Lupkovics G, Szapary L. Pusch G, et al. Among authors: gasztonyi b. J Cardiovasc Pharmacol. 2008 Dec;52(6):475-84. doi: 10.1097/FJC.0b013e31818eee5f. J Cardiovasc Pharmacol. 2008. PMID: 19034037 Review.
Aspirin resistance in cerebrovascular patients.
Feher A, Pusch G, Harang G, Gasztonyi B, Papp E, Werling D, Menyhart M, Komaromy H, Szapary L, Feher G. Feher A, et al. Among authors: gasztonyi b. Int J Cardiol. 2011 Oct 6;152(1):111-2. doi: 10.1016/j.ijcard.2011.07.028. Epub 2011 Jul 27. Int J Cardiol. 2011. PMID: 21794938 Clinical Trial. No abstract available.
[Chronic hepatitis B infection].
Gasztonyi B. Gasztonyi B. Orv Hetil. 2007 Jun 17;148(24):1142-3. doi: 10.1556/OH.2007.28140. Orv Hetil. 2007. PMID: 17561484 Hungarian. No abstract available.
Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials.
Clowse ME, Wallace DJ, Furie RA, Petri MA, Pike MC, Leszczyński P, Neuwelt CM, Hobbs K, Keiserman M, Duca L, Kalunian KC, Galateanu C, Bongardt S, Stach C, Beaudot C, Kilgallen B, Gordon C; EMBODY Investigator Group. Clowse ME, et al. Arthritis Rheumatol. 2017 Feb;69(2):362-375. doi: 10.1002/art.39856. Arthritis Rheumatol. 2017. PMID: 27598855 Free PMC article. Clinical Trial.
61 results